FRI-045-Treatment of patients with primary biliary cholangitis with seladelpar for 52 weeks improves predicted transplant-free survival

Authors :: Bettina E. Hansen
Yun-Jung Choi
Harry L.A. Janssen
Aliya Gulamhusein
Pol Boudes
M Varga
Carla F. Murillo Perez
Gideon M. Hirschfield
Alexandra Steinberg
Source :: Journal of Hepatology. 70:e403-e404
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: Transplant free survival
medicine.medical_specialty
Hepatology
business.industry
Internal medicine
Medicine
business
Gastroenterology

Full Text Access

Tools